J. Victor

Lenalidomide for Second-line Treatment of Advanced Hepatocellular Cancer: A Brown University Oncology Group Phase II Study

K. Faricy-Anderson, K. Perez, K. Charpentier, 2015, American journal of clinical oncology.

A phase 3 trial of hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer.

N. Aaronson, K. Sikorska, A. Aalbers, 2017 .

Lenalidomide for second-line treatment of advanced hepatocellular cancer (HCC): A Brown University Oncology Group phase II study.

J. Wands, K. Faricy-Anderson, K. Perez, 2012 .

Lenalidomide for advanced hepatocellular cancer (HCC) in patients progressing on or intolerant to sorafenib.

H. Safran, K. Faricy-Anderson, N. Espat, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.